{"database": "lobbying", "table": "lobbying_activities", "rows": [[669079, "4572c897-14c0-4361-bacf-4207c1713aac", "Q3", "GOODWIN PROCTER LLP", 79756, "TEVA PHARMACEUTICALS USA INC", 2008, "third_quarter", "PHA", "S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT (ALL PROVISIONS FOR ALL BILLS)", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2008-10-16T11:36:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["669079"], "units": {}, "query_ms": 10.049373959191144, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}